Evidence map›Paper›PMID 35522914›Full record

ArticleAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting2022

Early-Onset Colorectal Cancer Survival Differences and Potential Geographic Determinants Among Men and Women in Utah.

Charles R Rogers, Kevin M Korous, Ellen Brooks, Mary A De Vera, Fa Tuuhetaufa, Todd Lucas, Karen Curtin, Curt Pesman, Wenora Johnson, Phuong Gallagher and 1 more

Open access · greenAbstract read
In one paragraph

Article in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Young Onset Colorectal Cancer.South Asian journal of cancer · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Charles R RogersDepartment of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Kevin M KorousDepartment of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Ellen BrooksDepartment of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Mary A De VeraUniversity of British Columbia, Vancouver, British Columbia, Canada.
Fa TuuhetaufaDepartment of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Todd LucasDivision of Public Health, Michigan State University College of Human Medicine, Flint, MI.
Karen CurtinDepartment of Internal Medicine, Huntsman Cancer Institute, Utah Population Database Shared Resource, University of Utah School of Medicine, Salt Lake City, UT.
Curt PesmanBoCo Media, Boulder, CO.
Wenora JohnsonPatient-Centered Outcomes Research Institute, Chicago, IL.
Phuong GallagherThe Colon Club, Gansevoort, NY.
Justin X MooreMedical College of Georgia, Georgia Cancer Center, Cancer Prevention, Control, & Population Health, Augusta University, Augusta, GA.
University of Utah · USAugusta University · USPatient-Centered Outcomes Research Institute · USUniversity of British Columbia · CAUniversity of Michigan–Flint · US

Funding

Developing a Barbershop-Based Trial on Masculinity Barriers to Care and Colorectal Cancer Screening Uptake among African-American Men using a MixedMethods ApproachK01CA234319 · NCI · UNIVERSITY OF UTAH · PI ROGERS, CHARLES R. · 2018 to 2022
$878k
Geographic and Racial Disparities in Mammography Screening and Barriers to Receiving CareK01MD015304 · NIMHD · UNIVERSITY OF KENTUCKY · PI MOORE, JUSTIN XAVIER · 2020 to 2024
$646k
NCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS K01 CA234319NIMHD NIH HHS K01 MD015304
6 · The paper itself

Abstract

By 2030, early-onset colorectal cancer (EOCRC) is expected to become the leading cancer-related cause of death for people age 20 to 49. To improve understanding of this phenomenon, we analyzed the geographic determinants of EOCRC in Utah by examining county-level incidence and mortality. We linked data from the Utah Population Database to the Utah Cancer Registry to identify residents (age 18-49) diagnosed with EOCRC between 2000 and 2020, and we used spatial empirical Bayes smoothing to determine county-level hotspots. We identified 1,867 EOCRC diagnoses (52.7% in male patients, 69.2% in non-Hispanic White patients). Ten counties (34%) were classified as hotspots, with high EOCRC incidence or mortality. Hotspot status was unrelated to incidence rates, but non-Hispanic ethnic-minority men (incidence rate ratio, 1.49; 95% CI, 1.15-1.91), Hispanic White men and women (incidence rate ratio, 2.24; 95% CI, 2.00-2.51), and Hispanic ethnic-minority men and women (incidence rate ratio, 4.59; 95% CI, 3.50-5.91) were more likely to be diagnosed with EOCRC. After adjustment for income and obesity, adults living in hotspots had a 31% higher hazard for death (HR, 1.31; 95% CI, 1.02-1.69). Survival was poorest for adults with a late-stage diagnosis living in hotspots (chi square (1) = 4.0; p = .045). Adults who were married or who had a life partner had a lower hazard for death than single adults (HR, 0.73; 95% CI, 0.58-0.92). The risk for EOCRC is elevated in 34% of Utah counties, warranting future research and interventions aimed at increasing screening and survival in the population age 18 to 49.

Indexed as

Colorectal NeoplasmsAdolescentAdultBayes TheoremFemaleHumansIncidenceMaleMiddle AgedUtahYoung Adult

Identifiers

PMID35522914
PMCPMC9327138
OpenAlexW4229046480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.